CONMED's stock appears overpriced when gauged against the industry average PE ratio. Despite its positive outlook being factored into its valuation, the elevated price could present a risk to potential sellers and isn't the optimum entry point for potential investors.
wooper スレ主 : FYIが始まったばかりで、一日中実行されます